Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)

NCT00060554 is registered in ClinicalTrials.gov with Schering-Plough as lead sponsor.

NCT NCT00060554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00060554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
Lead sponsor
Schering-Plough
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2003
Completion date
Not reported
Enrollment
300
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease, myocardial infarction